Chesapeake-Ohio Pharmacokinetics Core supports cancer drug testing
Official title: The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
Funded at Johns Hopkins University · NIH-11500210 · Data updated 2026-11-12
A collaborative core lab helps researchers study how cancer drugs behave in the body to improve clinical trials and patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | March 1, 2026 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $493,090 |
| NIH project number | 3U24CA247648-06S1 |
| Project ID | NIH-11500210 on NIH RePORTER |
Who could benefit from this research
✓Could help
Enter patients enrolled in ETCTN cancer clinical trials and cancer patients whose drugs are analyzed in PK studies within the network.
✕Less likely to help
Patients not involved in ETCTN trials or whose samples are not part of the analyzed pharmacokinetic efforts may not directly benefit.
What this research studies
This grant funds a shared pharmacokinetics and bioanalytical core that designs, conducts, and analyzes pharmacology studies within the ETCTN cancer trial network. It brings together big-name institutions to analyze thousands of samples each year, ensuring accurate measurement of drug levels and understanding of how drugs act in people with cancer. The team improves study designs and data interpretation to speed the development of new anticancer therapies. The work focuses on translating lab measurements into actionable information for clinicians and patients participating in trials.
Why it matters
Potential benefit: If successful, patients could receive faster access to better cancer therapies with well-understood dosing and safety profiles.
How similar studies have gone: Previous pharmacokinetics cores have supported drug development by providing reliable PK data critical for dose selection and efficacy analyses.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Beumer, Jan Hendrik — Johns Hopkins University
- Study coordinator: Beumer, Jan Hendrik
Related research
Other NIH-funded projects on the same topics.
-
Sub-second acetylcholine release in the brain for Alzheimer’s dementia
A small, quick stimulations-based study aims to boost a brain chemical called acetylcholine to help people with Alzheimer’s disease by using a targeted brain stimulation approach.
-
Understanding how broadly neutralizing antibodies may help HIV cure trials
A study at UC San Francisco looks at how antibody medicines behave in people on and off HIV therapy to help design better cure strategies.
-
Improving HIV-related brain infections by studying how drugs reach the brain
This grant looks at how well drugs reach the brain and spine to treat HIV-related infections like cryptococcal meningitis and TB meningitis in people with AIDS.
-
Transdermal delivery patch for zanamivir to treat influenza in patients
A new skin patch delivers zanamivir to people with flu or at risk of flu, aiming for easier, safer treatment than pills.
-
Urine color test to check tuberculosis drug levels in children and adults
This project uses a simple urine color test to see whether children and adults with TB are getting enough of key TB medicines like rifampin.
-
Making brain-targeted protein degraders work for Alzheimer’s related dementia
A research project at UC San Diego aims to develop smarter drug molecules that can cross the brain barrier and selectively remove disease-related proteins linked to Alzheimer’s, with potential benefits for people living with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.